Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incobotulinumtoxin A and Yoga in Adolescent Idiopathic Lumbar Scoliosis
NCT04922983Phase 2Recruiting
- Sponsor
- Manhattan Physical Medicine and Rehabilitation
- Start
- Jul 2021
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of incobotulinumtoxinA in adolescent idiopathic scoliosis (AIS), sponsored by Manhattan Physical Medicine and Rehabilitation. Started Jul 2021; status: recruiting.
02
Drugs
incobotulinumtoxinA
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on NCT04922983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04922983.